Bristol-Myers Squibb Co (BMY) saw downtrend of -1.73% in the recent trading with $55.83 being its most recent. The current price level -8.60% lower than the highest price of $61.08 marked by the stock while trading over the past 52-weeks, whereas it is 41.88% higher than the lowest price of $39.35 the company dropped to over past 52-weeks. The latest news story on BMY appeared in (ACCESSWIRE) under the title “Bristol Myers Squibb Named to Dow Jones Sustainability Index North America for Second Consecutive Year”.
Squeezing the time span to 30 day period shows us the stock is currently trading -4.64% below one month high and is +1.44% above of the lowest during that time. Looking into the simple moving average, Bristol-Myers Squibb Co (BMY)’s stock stands at a SMA-50 of $57.14 while that of 5-day is reading $56.61.
Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and BMY’s SMA-200 as of now is $49.49.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Moderate Buy by 14 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 2.57 for the stock.
Bristol-Myers Squibb Co Earnings – What Happened With BMY
Coming around sales and income figures on BMY Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
BMY – Bristol-Myers Squibb Co Stock Earnings Estimates
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 2.03 billion. BMY does have institutional investors; and they hold 77.74% of the stock.
Bristol-Myers Squibb Co – Insider Activity and Holdings
As on 2024-06-30, VANGUARD GROUP INC was the top most holder in Bristol-Myers Squibb Co (NYSE:BMY) with an ownership of 186.57 million shares of the company or 9.2225 of the stake worth $7.75 billion. The filing also reveals BLACKROCK INC. as the second largest holder in the company with a control over 7.8428 of the outstanding shares. Its stake is worth $6.59 billion for having 158.66 million shares in hand.
STATE STREET CORP also came holding a key position in the company during the recent quarter and it now holds 4.5203 of the outstanding shares. With this there are now 2901.0 institutions which have possession in BMY’s shares.
Currently, the stock has been recommended as Moderate Buy by 14 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 2.57 for the stock.
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Bristol-Myers Squibb Co has a debt to equity ratio of 3.00.
Technical Analysis of Bristol-Myers Squibb Co (NYSE:BMY) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Bristol-Myers Squibb Co (BMY), we notice that the stock’s 20-day average volume is at 11,814,565 shares. Medium term indicators at an average of 50% are spotting the stock at Buy with its 50-day average volume of 11,349,742 shares. And to end, BMY’s 100-day average volume is 10,756,770 shares with 100% of the long-term indicators pointing towards Buy for the stock.
